Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Amlodipine Besylate, Olmesartan Medoxomil Drug Combination MeSH Descriptor Data 2026


MeSH Heading
Amlodipine Besylate, Olmesartan Medoxomil Drug Combination
Tree Number(s)
D03.383.129.308.674.500
D03.383.129.617.584.500
D03.383.725.203.065.500
D26.310.063
Unique ID
D000068558
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000068558
Scope Note
A pharmaceutical preparation of amlodipine besylate and olmesartan medoxomil that combines ANGIOTENSIN II TYPE I RECEPTOR ANTAGONIST and CALCIUM CHANNEL BLOCKER activities. It is used in the management of HYPERTENSION.
Entry Term(s)
Amlodipine Besylate, Olmesartan Medoxomil
Amlodipine Besylate-Olmesartan Medoxomil
Amlodipine Besylate-Olmesartan Medoxomil Drug Combination
Azor
Pharm Action
Antihypertensive Agents
Calcium Channel Blockers
Angiotensin II Type 1 Receptor Blockers
Registry Numbers
0
Previous Indexing
Amlodipine (2010-2015)
Antihypertensive Agents (2012-2015)
Public MeSH Note
2016
History Note
2016
Date Introduced
2016/01/01
Last Updated
2016/05/27
Amlodipine Besylate, Olmesartan Medoxomil Drug Combination Preferred
Azor Narrower
page delivered in 0.178s